OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110136893A1
SERIAL NO

12516439

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A conjugate or compound comprising polyethyleneglycol and an oligonucleotide, wherein at least one polyethyleneglycol is linked to the 5′-end of the oligonucleotide and at least one polyethyleneglycol is linked to the 3′-end of the oligonucleotide, wherein the molecular weight of the polyethyleneglycol linked to the 5′- and 3′-end of the oligonucleotide is identical and is <5000 Da, or wherein the molecular weight of the polyethyleneglycol linked to the 5′- and 3′-end of the oligonucleotide is different.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ANTISENSE PHARMA GMBHJOSEF-ENGERT-STRASSE 9 REGENSBURG D-93053

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fischer, Dagmar Regensburg, DE 9 13
Mitsch, Andreas Lappersdorf-Piehlmuhle, DE 3 87
Schlingensiepen, Karl-Hermann Donaustauf, DE 23 258
Schlingensiepen, Reimar Regensburg, DE 13 139

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation